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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYWNT signaling stimulates the self-renewal of many types of adult stem cells, including mammary stem cells (MaSCs), but mecha-
nisms that limit this activity are poorly understood. Here, we demonstrate that SLIT2 restricts stem cell renewal by signaling through
ROBO2 in a subset of basal cells to negatively regulate WNT signaling. The absence of SLIT/ROBO2 signaling leads to increased
levels of nuclear b-catenin. Robo2 loss does not increase the number of stem cells; instead, stem cell renewal is enhanced in the
absence of SLIT/ROBO2 signaling. This is due to repressed expression of p16 INK4a, which, in turn, delays MaSC senescence. Together,
our studies support a model in which SLITs restrict the expansion of MaSCs by countering the activity of WNTs and limiting self-
renewal.INTRODUCTION
SLITs are a conserved family of secreted proteins that partic-
ipate in numerous developmental processes by signaling
through ROBO receptors expressed on diverse cell types
(Ballard and Hinck, 2012). The bilayered ducts of the mam-
mary gland (MG) comprise an outer layer of basal cells
(BCs) and an inner layer of luminal cells (LCs) and grow
into a tree-like structure (Macias and Hinck, 2012). SLITs,
expressed throughout the gland, regulate the elongation
and branching of this structure during puberty by limiting
the proliferation of basal cap cells (Macias et al., 2011;
Strickland et al., 2006). BCs are capable of generating an
entire mammary epithelial tree when transplanted into a
cleared fat pad (Shackleton et al., 2006; Stingl et al.,
2006). However, this population is heterogeneous, con-
taining a small subset of MaSCs and a majority of differen-
tiated cells. Little is known aboutmechanisms that regulate
the growth, survival, and senescence of the basal MaSCs
(bMaSCs).
SLITs regulate cell proliferation in both normal BCs and
breast cancer cells by inhibiting AKT, leading to activation
of GSK3b, and resulting in reduced nuclear accumulation
of b-catenin and decreased expression of WNT-activated
genes (Macias et al., 2011; Prasad et al., 2008; Tseng et al.,
2010). Inhibition of b-catenin and canonical WNT
signaling by SLIT may be important in regulating MaSC
numbers becauseWNT3A enhances the self-renewal capac-
ity of bMaSCs in culture, stimulating their clonal expan-
sion while maintaining their ability to generate functional
glands upon transplantation (Zeng and Nusse, 2010).Stem CellAlthough expression of WNT1 or activated b-catenin re-
sults in an expanded bMaSC population and enhanced tu-
mor formation (Shackleton et al., 2006; Teulie`re et al.,
2005), less is known about the impact of inhibiting WNT
signaling. However, treatment of bMaSCs with the WNT
inhibitor DKK decreases formation of secondary colonies,
presumably by limiting self-renewal (Zeng and Nusse,
2010). Therefore, curbing WNT signaling through SLIT/
ROBO signaling may also restrict bMaSC self-renewal.
MaSC numbers must be tightly regulated through a bal-
ance of self-renewal, differentiation, and senescence to pre-
vent tumorigenesis, while accommodating high levels of
cell proliferation during pregnancy. Several secreted factors
such asWNTandHedgehog promote self-renewal, but little
is known about how this process is restricted (Cho et al.,
2013; Liu et al., 2006; Zeng and Nusse, 2010). Mechanisms
involving p53 signaling have been demonstrated, in which
bMaSC self-renewal is limited by either inhibiting symmet-
ric divisions (Cicalese et al., 2009) or increasing senescence
(Insinga et al., 2013). Additionally, inhibiting WNT
signaling by DKK upregulates senescence-associated cell
cycle inhibitor, p16 INK4a (CDKN2A) (Cho et al., 2013),
which is directly repressed by b-catenin (Delmas et al.,
2007). Here, we hypothesize that SLITs influence the self-
renewal of bMaSCs by regulating their senescence. Our
investigation identifies SLIT as an extracellular factor that
signals through its ROBO2 receptor to inhibit WNT
signaling, thereby regulating bMaSC senescence by gov-
erning the subcellular localization of b-catenin. As such,
SLITs are a class of nonrenewal factors for bMaSCs in
the MG.Reports j Vol. 3 j 385–393 j September 9, 2014 j ª2014 The Authors 385
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Loss of Robo2 Enhances bMaSC Self-Renewal In Vitro
To investigate the regulation of bMaSCs by SLIT/ROBO
signaling, we examined expression of the Robo1 and
Robo2 receptors in flow cytometry (FACS)-purified
BCs (Lin-CD24+CD29hi), mature luminal cells (Lin-
CD24loCD29+CD61; ML), and luminal progenitor cells
(Lin-CD24loCD29+CD61+; LP), harvested from the mature
virgin MG. Quantitative RT-PCR (qRT-PCR) analysis shows
expression of Robo1 and Robo2 in BCs, with a significant
enrichment of Robo2 expression in BCs as compared to
the ML and LP populations (Figures 1A and 1B). We have
previously published the localization of ROBO1 on cap/
BCs and a subpopulation of LCs (Macias et al., 2011; Mar-
low et al., 2008). To further confirm ROBO2 expression,
we performed immunohistochemistry (IHC) and find
ROBO2 expression in subpopulations of BCs and LCs
in vivo (Figure 1C) and in vitro (Figure 1D).
To determine if loss of SLIT/ROBO signaling leads to
changes in the self-renewal capacity of bMaSCs, we exam-
ined the ability of Robo1/ or Robo2/ FACS-purified BCs
to serially passage in 3D Matrigel colony assays. Wild-type
(WT) BCs possess a limited capacity for self-renewal (Fig-
ures 1E and 1G), with colonies progressively becoming
smaller until they senesce at passages 4–5 (Figures 1F and
1H). Loss of Robo1 does not confer an advantage in
passaging ability or colony size (Figures 1E and 1F). In
contrast, loss ofRobo2 leads to an increase in passaging abil-
ity (Figure 1G) and reduces the decline in colony size over
passage (Figures 1H–1J), suggesting that loss of Robo2 en-
hances bMaSC self-renewal.
SLIT2 Acts as a Nonrenewal Factor by Inhibiting
b-Catenin Activity in bMaSCs
The enhanced self-renewal observed in Robo2/ BCs sug-
gests that SLIT2 acts through ROBO2 to inhibit self-
renewal. To test this, BCs were treated with SLIT2 during
the initial plating and then grown in the absence of
SLIT2 in subsequent passages (Figures 2A and 2B). Analysis
of SLIT2-treated colonies at P1 reveals significantly smaller
colonies compared to control (Figure 2B). 5-ethynyl-20-de-
oxyuridine (EdU) incorporation was also significantly
reduced in SLIT2-treated colonies, compared to control
(data not shown). These data are consistent with our previ-
ous finding that SLIT2 acts through ROBO1 to inhibit BC
proliferation (Macias et al., 2011). We next determined
whether bMaSCs continue to self-renew when released
from the antiproliferative activity of SLIT2. Despite the
absence of exogenous SLIT2, BCs, initially treated with
SLIT2, are unable to self-renew and continue to exhibit
impaired proliferation as indicated by colony size (Figures
2A and 2B). These data support the hypothesis that SLIT2386 Stem Cell Reports j Vol. 3 j 385–393 j September 9, 2014 j ª2014 The Aacts not only to inhibit BC proliferation, but also as a
bMaSC nonrenewal factor.
Canonical WNT signaling enhances the self-renewal of
bMaSCs (Zeng and Nusse, 2010). To determine if SLIT2
acts as a nonrenewal factor by inhibiting the WNT
pathway, BCs were treated with SLIT2, WNT3A, or both.
Initial colony number, assessed at passage 1 (P1), is similar
between all treatment groups, although colonies treated
with SLIT, even in the presence of WNT3A, are smaller in
size (Figure 2C; data not shown). As previously published,
colonies treated with WNT3A alone show a marked in-
crease in colony number (Zeng and Nusse, 2010). Again,
colonies treated with SLIT2 alone cannot be passaged
past P2, even at a lower SLIT2 concentration. Treatment
with both SLIT2 and WNT3A greatly attenuates self-
renewal as indicated by reduced cumulative colony
numbers. Taken together, these data suggest that SLIT2 in-
hibits WNT-mediated self-renewal.
Previous research has shown that SLIT2 opposes WNT
signaling by regulating the AKT/GSK3b pathway and in-
hibiting the nuclear localization of b-catenin (Macias
et al., 2011; Prasad et al., 2008; Tseng et al., 2010). We
next examined whether loss of SLIT/ROBO2 signaling re-
sults in enhanced b-catenin activity in BC colonies by
examining localization of the activated form of b-catenin
(ABC) (Figures 2D and 2E). In Robo2+/+ colonies, ABC is
localized primarily to the membrane and throughout the
cytoplasm. In contrast, Robo2/ colonies have a more
diffuse localization of ABC. Although levels are similar in
the cytoplasm, less ABC is localized to the membrane.
Because b-catenin is only transcriptionally active in the nu-
cleus, we also analyzed nuclear ABC, as determined by co-
labeling with Hoechst, and found a significant increase in
Robo2/ colonies. Although we did not examine whether
increased nuclear ABC is localized specifically in BCs, anal-
ysis of colony composition using BC marker K14 and LC
marker K8 shows the majority of cells (60%–70%) in both
Robo2+/+ and Robo2/ colonies are K14+ (data not shown).
This, in conjunction with our finding that ROBO2 colocal-
izes with BC marker p63 in Robo2+/+ colonies (Figure 1D),
suggests that loss of Robo2 is likely regulating b-catenin
signaling in at least a subpopulation of BCs. To determine
if increased nuclear b-catenin leads to upregulation of
stem cell related target genes, we examined transcriptional
levels of Myc, Jun, and Tert (Hoffmeyer et al., 2012; Jiao
et al., 2010; Moumen et al., 2013). We find that all three
genes show increased expression in Robo2/ BC colonies,
although only Myc reaches significance (Figure 2F).
Together, these data suggest that loss of Robo2 leads to
increased b-catenin signaling in BC colonies.
To determine if increased nuclear ABC in Robo2/ BC
colonies is due to loss of SLIT/ROBO2 signaling and not





Figure 1. Loss of ROBO2 Enhances BMaSC Self-Renewal
(A and B) (A) qRT-PCR of Robo1 and (B) Robo2 mRNA expression in FACS-purified basal (B), luminal progenitor (LP), and mature luminal
cells (MLs). (t test: Robo2 LP *p = 0.0229, Robo2 ML *p = 0.0286; n = 3).
(C) ROBO2 and p63 IHC on Robo2+/+ duct. Arrows: ROBO2 at the membrane of p63+ cells. Arrowhead: ROBO2 at the membrane of p63- cells
touching the basal lamina. Bottom row: Robo2/ control. L, lumen (scale bar, 50 mm).
(D) ROBO2/p63 IHC on Robo2+/+ basal colony. Arrows: ROBO2 in p63+ cells (scale bar, 50 mm).
(E and G) Matrigel colony numbers from an initial 20K Robo1(E) or Robo2(G) cells over serial passages (G: one-way ANOVA, Bonferroni post
hoc test ***p = < 0.001; two-way ANOVA, significant interaction genotype and passage **p < 0.01, n = 3.
(F and H) Robo1(F) and Robo2(H) colony size at each passage (one-way ANOVA, Bonferroni post hoc test ***p < 0.001).
(I and J) Representative images of Robo2 colonies at P1(I) and P5 (J) (scale bar, 250 mm; insets, 50 mm).
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Figure 2. SLIT2 Acts as a Nonrenewal Fac-
tor by Inhibiting b-Catenin Activity in
bMaSCs
(A and B) (A) Matrigel colony numbers and
colony size (B) from an initial 20K control or
SLIT2 (2 mg/ml) -treated WT colonies over
serial passages (A: paired t test *p = 0.0482,
n = 3) (B: one-way ANOVA, Bonferroni post
hoc test: ***p < 0.0001, *p = 0.0261).
(C) Colony numbers after treatment with
0.5 mg/ml SLIT2, 2 mg/ml SLIT2, 100 ng/ml
WNT3A, or both over serial passages (one-
way ANOVA, post hoc t test: P2: C versus
2 mg/ml SLIT2 p = 0.0492, C versus 2 mg/ml
SLIT2+ WNT3a: p = 0.0717; P3: ***p < 0.001,
n = 3).
(D) Representative confocal images of
activated-b-catenin IHC (ABC; red) and
Hoechst (blue) on Robo2 colony sections
(left scale, 50 mm; right scale, 10 mm).
(E) Relative levels of ABC expression de-
tected using ImageJ to determine the
average pixel intensity (t test: ***p < 0.001,
n = 5).
(F) qRT-PCR analysis of relative b-catenin
target gene expression in Robo2+/+ and
Robo2/ basal colonies (*p= 0.0329, n = 3).
(G) Robo2 colony numbers at P1 and P2 of
cells treated with 1 mg/ml DKK1 (two-way
ANOVA,Bonferroni posttest: *p <0.05, n =3).
(H) Robo2 colonies were cultured and
passaged in the presence of DMSO or the PI3/
AKT inhibitor LY294002 (5 mM) (one-tailed t
test, *p = 0.0497, **p = 0.0049, n = 3).
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WNT signaling (Figure 2G). DKK1 is a secreted factor that
inhibits WNT signaling upstream by interfering with
LRP5/6 receptor function, and it has been shown to inhibit
BC colony self-renewal (Zeng and Nusse, 2010). Accord-
ingly, we find that treatment of Robo2+/+ colonies with
DKK1 leads to reduced secondary colony formation; how-
ever, Robo2/ colonies are resistant to DKK1 treatment
and exhibit a significant increase in secondary colony
formation (Figure 2G). These results show that inhibition
of WNT signaling via DKK1 is insufficient to block self-
renewal in bMaSCs that have lost SLIT/ROBO2 signaling.
The fact that in the absence of Robo2 there is increased nu-388 Stem Cell Reports j Vol. 3 j 385–393 j September 9, 2014 j ª2014 The Aclear b-catenin (Figures 2D and 2E), along with enhanced
BC colony renewal (Figure 1G), even under DKK1 treat-
ment conditions (Figure 2G), suggests that the loss of
SLIT/ROBO2 enhances bMaSC renewal directly by
increasing nuclear b-catenin signaling. To further examine
if stem cell renewal is increased in Robo2/ cells through
activation of the PI3K/AKT/GSK-b pathway, we treated
Robo2+/+ and Robo2/ colonies with AKT inhibitor
LY294002 (Figure 2H). We find that AKT inhibition signif-
icantly impedes renewal in Robo2/ colonies, suggesting
that the PI3 kinase pathway is indeed a key pathway pro-
moting b-catenin-mediated self-renewal in the absence of
ROBO2.uthors
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Figure 3. SLIT2/ROBO2 Signaling Pro-
motes bMaSC Senescence by Derepressing
p16INK4a Expression
(A) qRT-PCR quantification of p16 INK4a
mRNA in P1 and P4 Robo2 colonies (t test:
P1*p = 0.0185, P4 *p = 0.0119, n = 3).
(B and C) IHC of p16 INK4a (red) and DAPI
(blue) in Robo2+/+(B) and (C) Robo2/ P4
colonies (scale bar, 20 mm).
(D) Quantification of p16 INK4a fluorescent
intensity (n = 20–25).
(E) qRT-PCR for p16 INK4a mRNA in control or
SLIT2- (2 mg/ml) treated (2 weeks) Robo2
colonies (t test:*p = 0.0354, n = 3).
(F) SA-b-gal in Robo2 colonies over serial
passages.
(G) Low senescence P1 (top) and P4
Robo2/ colonies (bottom, right), high
senescence P4 Robo2+/+ colony (bottom,
left) (t test*p < 0.05; scale bar, 50 mm; n =
2–4).
(H) Expression of SA-b-gal in SLIT2-treated
colonies (t test, *p = 0.0410, **p = 0.0025,
n = 3).
(I) Example of low senescence (%50% blue)
control colony (top) and high senescence
(>50% blue) SLIT2-treated colony (bottom)
scale bar, 50 mm.
(J) SLIT2 induces SA-b-gal expression in
Robo2+/+ colonies, but not Robo2/ col-
onies (paired t test *p = 0.0142, n = 3).
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by Derepressing P16 INK4a Expression
The results from the serial passaging assay suggest that one
possible mechanism through which SLIT2 acts as a nonre-
newal factor is by promoting senescence in bMaSCs and
their offspring. P16INK4a is a cell-cycle inhibitor that medi-
ates cellular senescence. Previous studies show that b-cate-
nin immortalizes skin melanocytes by directly binding to
and silencing the p16INK4a promoter (Delmas et al., 2007).
We first looked at expression of p16 INK4a by qRT-PCR
and, although both Robo2+/+ and Robo2/ colonies have
higher levels of p16INK4a at P4 compared to P1, Robo2/
colonies have significantly attenuated levels (Figure 3A).
Next, we evaluated p16INK4a at passages P1 and P4 by IHC
(Figures 3B–3D). At P1, little p16INK4a expression is
observed (not shown), but at P4, significantly higher levels
of p16 are detected in both the cytoplasm and nucleus of
WT colonies, whereas its expression is significantly lower
in Robo2/ colonies (Figure 3D). We also examined the
expression of p16 INK4a mRNA in colonies that were chron-
ically treated with SLIT2 and find that SLIT2 promotes
p16 INK4a expression in Robo2+/+ colonies and loss ofStem CellRobo2 blocks this increase (Figure 3E). These data show
that loss of SLIT/ROBO2 signaling in late passage BC col-
onies leads to attenuated expression of p16 INK4a and sug-
gest that, similar to melanocytes, increased nuclear b-cate-
nin in Robo2/ colonies represses p16 INK4a expression and
consequently inhibits senescence (Delmas et al., 2007).
To determine if loss of SLIT/ROBO2 signaling inhibits
senescence, we examined senescence-associated b-galacto-
sidase (SA-b-Gal) expression in Robo2+/+ and Robo2/ BC
colonies. At P1, there is no difference in senescence; how-
ever, as colonies are passaged, Robo2+/+ colonies undergo
a continual increase in senescence, whereas Robo2/ col-
onies maintain a fairly stable rate of senescence similar to
P1 (Figures 3F and 3 G). To examine if, conversely, SLIT/
ROBO2 signaling promotes senescence in BC colonies, we
analyzed SA-b-Gal expression 24 and 72 hr after SLIT2
treatment. By 72 hr, colonies treated with SLIT2 display a
significant increase in SA-b-Gal expression (Figures 3H
and 3I) that does not occur in Robo2/ colonies (Figure 3J).
Together, these data demonstrate that SLIT/ROBO2
signaling positively regulates p16INK4a expression and pro-





Figure 4. Loss of SLIT/ROBO2 Signaling
Enhances MaSC Self-Renewal In Vivo
(A, C, and E) Fragments of littermate +/+,
Robo1/ (A; n = 4), Robo2/ (C; n = 7), or
Slit2/;Slit3/ (E; n = 3) MG were serially
transplanted and assessed at 8 week intervals
(generations) (C: t test; G3 #p = 0.0699, G4
**p = 0.0033, G5 *p = 0.0403, G6 *p =
0.0182; E: paired t test; G6 **p = 0.0015.
(B, D, and F) FACS analysis of basal cells
within the WT, Robo1/ (B; n = 5–14 MG/
time point [tp]), Robo2/ (D; n = 5–20 MG/
tp), or Slit2/;Slit3/ (F; n = 5–20 MG/tp)
MG (D: paired t test: G1 *p = 0.0199, G2 **p =
0.0077, G3 **p = 0.0043, G4 ***p = 0.0002,
G5 ***p < 0.001, G6 **p = 0.0022, G7 ***p <
0.0001, G8 *p = 0.0138; F: Paired t test; G4
#p = 0.0796, G5 **p = 0.0038, G6 *p =
0.0184, G7 ***p = 0.0002, G9 **p = 0.0025,
G10 *p = 0.0154).
(G) Carmine stained whole mounts from WT
(top) and Slit2/;Slit3/(bottom) out-
growths (scale bar, 300 mm).
(H) qRT-PCR of FACS-purified basal cells from
Robo2+/+ and Robo2/ transplant glands at
G1 and G6 (t test *p = 0.0271, n = 3).
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To investigate whether loss of SLIT/ROBO2 signaling im-
pairs MaSC self-renewal in vivo, we performed serial MG
transplantations. As previously demonstrated (Daniel
et al., 1968),WTMG fragments can be serially transplanted
four to five times, before no further outgrowths are ob-
tained (Figures 4A, 4C, 4E, and 4G). Similar to our
in vitro findings (Figure 1D), loss of Robo1 does not confer
a self-renewal advantage in the serial transplantation assay
(Figure 4A). In contrast, loss of either Robo2 or Slit2;Slit3
leads to a nearly 2-fold increase in the number of transplant
generations (Figures 4C, 4E, and 4G). These results demon-
strate that loss of SLIT/ROBO2 signaling enhances MaSC
self-renewal.
One explanation for the observed increased transplant-
ability of Robo2/ and Slit2/;Slit3/ tissue is that390 Stem Cell Reports j Vol. 3 j 385–393 j September 9, 2014 j ª2014 The Aknockout (KO) tissue contains more bMaSCs. To investi-
gate, we analyzed MG cell populations by FACS at each
generation. There is no significant increase in the
percent of BCs at generation 1 (G1) in any genotype,
showing that transplantation itself does not expand
this population. The BC population, however, is retained
at higher levels over serial transplantation in KO out-
growths. Moreover, the rate of decline of the BC popula-
tion is more gradual in KO outgrowths, suggesting that
bMaSCs may be retained in this tissue (Figures 4D and
4F). Because the BC population is not pure, but only en-
riched for bMaSCs, we also performed limiting dilution
assays using BCs derived from either G0 Robo2+/+ or
Robo2/ glands, or G4 serially transplanted Robo2+/+
and Robo2/ outgrowths. We found that the lack of
Robo2 in G0 glands does not result in an expansion in
bMaSCs, with Robo2+/+ frequency estimated at 1/127uthors
Stem Cell Reports
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at 1/145 (95% CI 1/87–1/241). However, we found a
remarkable retention of bMaSCs in serially transplanted
Robo2/ glands at G4 (Robo2+/+ frequency 1/1,737
(95% CI 1/753–1/4,008); and Robo2/ frequency 1/196
(95% CI 1/77–1/498). These studies show that intact
Robo2/ glands do not contain more bMaSCs, but rather
that Robo2/ bMaSCs do not senesce as rapidly as
Robo2+/+ bMaSCs. In support of this hypothesis, we
examined expression of p16INK4a in FACS-purified cells
from Robo2+/+ and Robo2/ transplant glands from G1
and G6. We find that, similar to P1 Robo2/ colonies
(Figure 3A), Robo2/ BCs have significantly lower
expression of p16INK4a at G1 (Figure 4H). At G6, when
Robo2+/+ has already senesced, we find increased levels
of p16INK4a in comparison to G1 levels in Robo2/ BCs,
consistent with our hypothesis that loss of Robo2 delays,
but does not prevent, senescence. Taken together, the
data support a model in which SLIT2 acts as a nonre-
newal factor for bMaSCs by acting through ROBO2 to
oppose WNT signaling, and that loss of SLIT/ROBO2
signaling delays cellular senescence by increasing the nu-
clear localization of b-catenin and repressing p16INK4a
expression.DISCUSSION
Here, we show that SLITs act through ROBO2 to inhibit
self-renewal of bMaSCs. The actions of SLIT/ROBO
signaling on cells, including stem cells, appear to be tissue
and context specific, reminiscent of the context-depen-
dent roles this signaling pathway plays as both attractant
and repellent in cell migration (Ballard and Hinck, 2012).
A recent study found that SLIT2/ROBO1 cooperates with
R-spondin in intestinal stem cells to support their divi-
sion and increase their self-renewal capacity, presumably
by enhancing Wnt/b-catenin signaling (Zhou et al.,
2013). In contrast, in this study on bMaSCs, we show
an opposite effect with SLIT2 signaling through its
ROBO2 receptor to limit bMaSC self-renewal by promot-
ing senescence. Thus, although current data support an
important role for SLIT signaling in modulating WNT
signaling, its regulation appears to be dependent on
both the cellular context in which that signal is received
and the specific ROBO receptor mediating the signal.
Within a single tissue, we have shown that loss of either
ROBO1 or ROBO2 increases mammary BC nuclear b-cate-
nin levels, but with very different outcomes: whereas
loss of Robo1 leads to increased cell proliferation (Macias
et al., 2011), loss of Robo2 results in increased bMaSC
self-renewal. During pregnancy a similar dichotomy of
function appears to occur, with loss of Robo1 delaying al-Stem Cellveologenesis, whereas loss of Robo2 enhances it (J.C. and
L.H., unpublished data). Although multiple mechanisms
have been shown to increase nuclear b-catenin in
response to loss of SLIT/ROBO signaling (Grossmann
et al., 2013; Prasad et al., 2008; Tseng et al., 2010), it is
not yet understood how this leads to divergent expression
of WNT target genes such as those regulating prolifera-
tion and self-renewal. Determining the mechanism by
which b-catenin activates and represses select WNT target
genes remains a question of great interest in both the
SLIT/ROBO and WNT signaling fields (Archbold et al.,
2012).
Whereas SLITs have previously been characterized as me-
diators of adhesion, migration, and proliferation, our find-
ings demonstrate another role for SLIT in regulating
cellular senescence through its ROBO2 receptor. In identi-
fying this function, our data further elucidate how SLIT
acts as a tumor suppressor and how its loss contributes to
tumor progression. A recent study found SLIT/ROBO
signaling altered in 40.7% of basal, 12.3% of luminal A,
and 26.3% of luminal B type tumors (Network, 2012). We
show that by increasing the nuclear accumulation of b-cat-
enin, loss of SLIT/ROBO2 signaling inhibits expression of
p16 INK4a, itself a potent suppressor of tumors through its
regulation of the cell cycle (Rayess et al., 2012). In the
breast, silencing of p16 INK4a generates a preclonal phase
of tumorigenesis in which cells are positioned for progres-
sion to malignancy (Bean et al., 2007). Loss of p16INK4a
expression also increases the percentage of cancer stem
cells (CD44+/CD24) in basal-like breast cancer cell lines
and reduces their response to chemotherapeutic agents
(Arima et al., 2012). Thus, together with previous studies
on SLIT signaling in the breast, current data suggest that
SLITs inhibit breast tumorigenesis not only by decreasing
cellular proliferation through ROBO1 (Macias et al., 2011;
Prasad et al., 2008), but also by promoting cellular senes-
cence through ROBO2.EXPERIMENTAL PROCEDURES
Mouse Strains
Slit2, Slit3, Robo1, and Robo2/ mice were generated as previously
described (Strickland et al., 2006). The study conforms toUCSC an-
imal care committee (IACUC) guidelines.Statistics
Limiting dilution analysis was performed as previously described
(Shackleton et al., 2006). Statistics were performed using Prism
software (GraphPad). Error bars in all panels represent the SEM;
n = number of independent experiments, unless otherwise noted.
Transplant techniques, antibodies, IHC, SA-b-Gal assay, qRT-
PCR, cell preparation, and sorting are described in Supplemental
Experimental Procedures (available online).Reports j Vol. 3 j 385–393 j September 9, 2014 j ª2014 The Authors 391
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Supplemental Information includes Supplemental Experimental
Procedures and can be found with this article online at http://dx.
doi.org/10.1016/j.stemcr.2014.07.007.
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